VOYA INVESTMENT MANAGEMENT LLC - ACELRX PHARMACEUTICALS INC ownership

ACELRX PHARMACEUTICALS INC's ticker is ACRX and the CUSIP is 00444T100. A total of 70 filers reported holding ACELRX PHARMACEUTICALS INC in Q2 2019. The put-call ratio across all filers is 2.51 and the average weighting 0.0%.

Quarter-by-quarter ownership
VOYA INVESTMENT MANAGEMENT LLC ownership history of ACELRX PHARMACEUTICALS INC
ValueSharesWeighting
Q1 2021$63,000
+34.0%
37,211
-1.9%
0.00%
Q4 2020$47,000
+23.7%
37,935
+43.5%
0.00%
Q3 2020$38,000
+18.8%
26,4340.0%0.00%
Q2 2020$32,000
-34.7%
26,434
-36.0%
0.00%
Q1 2020$49,000
-43.7%
41,3060.0%0.00%
Q4 2019$87,000
+35.9%
41,306
+41.0%
0.00%
Q3 2019$64,000
-13.5%
29,3050.0%0.00%
Q2 2019$74,00029,3050.00%
Other shareholders
ACELRX PHARMACEUTICALS INC shareholders Q2 2019
NameSharesValueWeighting ↓
Perceptive Advisors 5,995,760$16,129,0001.12%
Palo Alto Investors LP 1,425,439$3,834,0000.29%
Granahan Investment Management 1,438,736$3,870,0000.14%
WealthTrust Axiom LLC 130,000$349,0000.13%
SHEPHERD KAPLAN KROCHUK, LLC 127,846$344,0000.09%
NIPPON LIFE INSURANCE CO 17,192$2,247,0000.06%
Joel Isaacson & Co., LLC 80,660$217,0000.05%
Cornerstone Capital, Inc. 47,200$127,0000.03%
OXFORD ASSET MANAGEMENT LLP 153,769$414,0000.01%
BRIDGEWAY CAPITAL MANAGEMENT, LLC 281,650$758,0000.01%
View complete list of ACELRX PHARMACEUTICALS INC shareholders